Panaceaventure
37+Portfolio
Focus on life sciences breakthroughs, incubating early‑stage companies with technologies that address unmet medical needs on a global scale.
Where they invest
Geography
Portfolio footprintHover a country to explore
- United States of America
- 53.6%
- United Kingdom
- 10.7%
- Brazil
- 3.6%
- People's Republic of China
- 3.6%
- Denmark
- 3.6%
- Other
- 10.8%
Darker countries represent a larger share of the portfolio.
What they back
Industries
- Biotechnology
- 53.6%
- Artificial Intelligence
- 32.1%
- Enterprise Software
- 21.4%
- Data & Analytics
- 14.3%
- Healthcare Technology
- 14.3%
- Digital Health
- 14.3%
% of all portfolio companies. Industry categories can overlap.
Stages
Stage indicator
No stages listed